Citation Impact
Citing Papers
Suppression of bone resorption by madindoline A, a novel nonpeptide antagonist to gp130
2002 StandoutNobel
Treatment of spinal osteoporosis in postmenopausal women.
1980
Bone density at various sites for prediction of hip fractures
1993 Standout
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
2001 Standout
Effects of Estrogen Plus Progestin on Risk of Fracture and Bone Mineral Density<SUBTITLE>The Women's Health Initiative Randomized Trial</SUBTITLE>
2003 Standout
Bacterial Diversity in the Human Gut
2004
Bone Formation Rate in Older Normal Women: Concurrent Assessment with Bone Histomorphometry, Calcium Kinetics, and Biochemical Markers*
1988
Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
1998 Standout
Host-microbial symbiosis in the mammalian intestine: exploring an internal ecosystem
1998
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Benefits and risks of menopausal estrogen and/or progestin hormone use
1988
Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
1999 Standout
Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy
2002 Standout
Diagnosis of osteoporosis and assessment of fracture risk
2002 Standout
Effect of Calcium and Vitamin D Supplementation on Bone Density in Men and Women 65 Years of Age or Older
1997 Standout
Hip Fracture and the Use of Estrogens in Postmenopausal Women
1987
The Protective Effects of Estrogen on the Cardiovascular System
1999 Standout
Legumes and soybeans: overview of their nutritional profiles and health effects
1999 Standout
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
1992 Standout
A Comparison of Observational Studies and Randomized, Controlled Trials
2000 Standout
Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture
2006 Standout
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
2001 Standout
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
1996 Standout
V. Meta-Analysis of the Efficacy of Hormone Replacement Therapy in Treating and Preventing Osteoporosis in Postmenopausal Women
2002
Superior compliance and efficacy of continuous combined oral estrogen-progestogen replacement therapy in postmenopausal women
1995
Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
1998 Standout
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
1999 StandoutNature
Cost Effectiveness of Screening Perimenopausal White Women for Osteoporosis: Bone Densitometry and Hormone Replacement Therapy
1990
Epidemiology of Hip Fractures
1997
Screening for Osteoporosis
1990
Histochemical evaluation of placental angiotensinase A in pre-eclampsia: Enzyme activity in villous trophoblast indicates an enhanced likelihood of gestational proteinuric hypertension
1996
Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report
1994 Standout
Vitamin D3and Calcium to Prevent Hip Fractures in Elderly Women
1992 Standout
THE PATHOPHYSIOLOGY AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS
1997
Effect and Offset of Effect of Treatments for Hip Fracture on Health Outcomes
1999
Estrogen plus Progestin and the Risk of Coronary Heart Disease
2003 Standout
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections
2020 Standout
Timing of postmenopausal estrogen for optimal bone mineral density. The Rancho Bernardo Study
1997
Postmenopausal Estrogen Therapy and Cardiovascular Disease
1991 Standout
Pharmacology of estrogens and progestogens: influence of different routes of administration
2005
Production and Actions of Estrogens
2002 Standout
A clinical trial on the effects of a combination of elcatonin (Carbocalcitonin) and conjugated estrogens on vertebral bone mass in early postmenopausal women
1993
Epidemiology and outcomes of osteoporotic fractures
2002 Standout
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System
2005 Standout
Bone mineral density in women with breast cancer treated with adjuvant tamoxifen for at least two years
1988
Spinal Bone Loss and Ovulatory Disturbances
1990
Effect of Discontinuation of Estrogen, Calcitriol, and the Combination of Both on Bone Density and Bone Markers
2002
Hormonal Treatment of Postmenopausal Women
1994
Renin-angiotensin system: biochemistry and mechanisms of action.
1977 Standout
Blood Pressures and Cardiovascular Homeostasis in Mice Having Reduced or Absent Angiotensin-Converting Enzyme Gene Function
1997 StandoutNobel
Involutional Osteoporosis
1986 Standout
Postmenopausal Bone Loss Is Prevented by Treatment with Low-Dosage Estrogen with Calcium
1987
Aberrant Renal Vascular Morphology and Renin Expression in Mutant Mice Lacking Angiotensin-Converting Enzyme
1997 StandoutNobel
Expression of Renin and Angiotensinogen Genes in the Human Placental Tissues.
1987
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Effect of combined therapy with phosphate and calcitonin on bone volume in osteoporosis
1980
Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications
2001 Standout
Scoliosis and Fractures in Young Ballet Dancers
1986 Standout
Guidelines for the Primary Prevention of Stroke
2014 Standout
Angiotensin-converting enzyme inhibitor fetopathy.
1993
Postmenopausal estrogens in prevention of osteoporosis. Benefit virtually without risk if cardiovascular effects are considered
1986
Impact of Psychological Factors on the Pathogenesis of Cardiovascular Disease and Implications for Therapy
1999 Standout
Risedronate Increases Bone Mass in an Early Postmenopausal Population: Two Years of Treatment Plus One Year of Follow-Up1
1998
Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women
1995 Standout
CHANGES IN THE RENIN‐ANGIOTENSIN SYSTEM IN PRIMIGRAVIDAE WITH HYPERTENSIVE DISEASE OF PREGNANCY
1975
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis*
2000 Standout
A Prospective Study of the Prevalence of the Polycystic Ovary Syndrome in Unselected Caucasian Women from Spain1
2000 Standout
High-Dose gestagens modulate bone resorption and formation and enhance estrogen-induced endosteal bone formation in the ovariectomized mouse
1993
Estrogen and Coronary Heart Disease in Women
1991 Standout
The Renin-Angiotensin System
1974
Estrogen-induced osteogenesis in intact female mice lacking ERβ
2002 StandoutNobel
Fractured Neck of Femur in the Elderly: An Attempt to Identify Patients at Risk
1979
Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
2002 Standout
Risk Factors for Hip Fracture in White Women
1995 Standout
From in vitro to in vivo Models of Bacterial Biofilm-Related Infections
2013
DIFFERENCES IN SERUM BONE GLA PROTEIN WITH AGE AND SEX
1984
Postmenopausal osteoporosis : Proposed roles of defective coupling and estrogen deficiency
1981
Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase
1995 StandoutScience
UNIDENTIFIED CURVED BACILLI IN THE STOMACH OF PATIENTS WITH GASTRITIS AND PEPTIC ULCERATION
1984 Standout
Decreased Risk of Fractures of the Hip and Lower Forearm with Postmenopausal Use of Estrogen
1980
Prevention of early postmenopausal bone loss: controlled 2‐year study in 315 normal females
1980
Interventions for preventing falls in older people living in the community
2012 Standout
PREVENTION OF SPINAL OSTEOPOROSIS IN OOPHORECTOMISED WOMEN
1980
BONE MASS IN POSTMENOPAUSAL WOMEN AFTER WITHDRAWAL OF OESTROGEN/GESTAGEN REPLACEMENT THERAPY
1981
Hip Fracture and the Use of Estrogens in Postmenopausal Women
1988
Estrogen inhibits the vascular injury response in estrogen receptor β-deficient female mice
1999 StandoutNobel
Spiral organisms in endoscopic biopsies of the human stomach.
1984
Angiotensins I and II, active and inactive renin, renin substrate, renin activity, and angiotensinase in human liquor amnii and plasma
1975
Works of A. Kraszewski being referenced
Prospective double-blind trial of synthetic steroid (Org OD 14) for preventing postmenopausal osteoporosis.
1980
Intestinal spirochaetosis
1971
Bone loss during oestriol therapy in postmenopausal women
1979
PLASMA RENIN, RENIN SUBSTRATE, ANGIOTENSIN II, AND ALDOSTERONE IN HYPERTENSIVE DISEASE OF PREGNANCY
1973
BONE RESPONSE TO TERMINATION OF ŒSTROGEN TREATMENT
1978
BONE RESPONSE TO TERMINATION OF OESTROGEN TREATMENT
1978
Comparative Effects of Oestrogen and a Progestogen on Bone Loss in Postmenopausal Women
1978